.Pharmacolibrary.Drugs.H_SystemicHormonalPreparationsExclSexHormonesAndInsulins.H01A_AnteriorPituitaryLobeHormonesAndAnalogues.H01AC09_Lonapegsomatropin.Lonapegsomatropin .Pharmacolibrary.Drugs.H_SystemicHormonalPreparationsExclSexHormonesAndInsulins.H01A_AnteriorPituitaryLobeHormonesAndAnalogues.H01AC09_Lonapegsomatropin.Lonapegsomatropin| name: | Lonapegsomatropin |
| ATC code: | H01AC09 | route: | subcutaneous |
| n-compartments | 2 |
Lonapegsomatropin is a long-acting prodrug of somatropin (recombinant human growth hormone) designed for once-weekly subcutaneous administration to treat pediatric patients with growth hormone deficiency. It is FDA and EMA approved for pediatric and adolescent use.
Population pharmacokinetics in pediatric patients with growth hormone deficiency based on two-compartment model with first-order absorption following subcutaneous injection.